Agilon Health (NYSE:AGL) Trading Down 5% – Time to Sell?

Shares of Agilon Health, Inc. (NYSE:AGL) dropped 5% during mid-day trading on Monday . The company traded as low as $121.65 and last traded at $123.2930. 59,013 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 349,783 shares. The stock had previously closed at $129.84.

Analyst Ratings Changes

AGL has been the topic of several research analyst reports. Barclays upgraded Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a research report on Tuesday, May 26th. Robert W. Baird lifted their target price on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Wells Fargo & Company reissued an “overweight” rating and issued a $141.00 price target (up from $72.00) on shares of Agilon Health in a report on Monday, July 13th. Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $27.50 to $48.00 in a research note on Thursday, May 7th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $64.00.

Agilon Health Trading Down 6.4%

The stock has a market cap of $2.03 billion, a PE ratio of -5.64 and a beta of 2.98. The stock has a 50-day moving average price of $100.84 and a two-hundred day moving average price of $47.73. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. Sell-side analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AGL. LPL Financial LLC boosted its position in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the last quarter. Krilogy Financial LLC purchased a new stake in Agilon Health during the fourth quarter valued at $34,000. CIBC Bancorp USA Inc. bought a new position in Agilon Health during the third quarter valued at $34,000. Merit Financial Group LLC bought a new position in Agilon Health during the fourth quarter valued at $35,000. Finally, Focus Partners Advisor Solutions LLC purchased a new position in shares of Agilon Health in the 4th quarter worth $53,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.